Richard Croarkin

Insider Reports History

Entity
Individual
Location
C/O Aerie Pharmaceuticals, Inc., 2030 Main Street, Suite 1500, Irvine, CA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Croarkin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Clearside Biomedical, Inc. Director Stock Option (right to buy) 45K Jun 20, 2024 Direct
AERIE PHARMACEUTICALS INC Director Common Stock 0 $15.25 Nov 21, 2022 Direct
AERIE PHARMACEUTICALS INC Director Stock Option (right to buy) 0 $9.14 Nov 21, 2022 Direct

Insider Reports Filed by Richard Croarkin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLSD Clearside Biomedical, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
CLSD Clearside Biomedical, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
AERI AERIE PHARMACEUTICALS INC Nov 21, 2022 4 -$535K 4 Nov 21, 2022 Director
CLSD Clearside Biomedical, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
AERI AERIE PHARMACEUTICALS INC Jun 9, 2022 2 $0 4 Jun 13, 2022 Director
AERI AERIE PHARMACEUTICALS INC Jun 17, 2021 2 $0 4 Jun 21, 2021 Director
CLSD Clearside Biomedical, Inc. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director